{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:31:10Z","timestamp":1794490270751,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.trre.2026.101038","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:33:34Z","timestamp":1782862414000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meta-analysis of the impact of donor hepatitis C infection on kidney transplantation outcomes"],"prefix":"10.1016","volume":"40","author":[{"given":"Alexander A.","family":"Dermanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Koimtzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101038_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2023.0526","article-title":"The organ shortage continues to be a crisis for patients with end-stage kidney disease","volume":"158","author":"Matas","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2026.101038_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1159\/000548765","article-title":"How to enhance kidney donation around the world: a summary of expert opinions from the 5th international congress of Chinese nephrologists","volume":"11","author":"Li","year":"2025","journal-title":"Kidney Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2018.11.009","article-title":"Mortality and kidney transplantation outcomes among Hepatitis C Virus\u2013seropositive maintenance dialysis patients: a retrospective cohort study","volume":"73","author":"Sawinski","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10277","article-title":"Kidney transplantation from hepatitis-C viraemic donors: considerations for practice in the United Kingdom","volume":"35","author":"Doherty","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101038_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100677","article-title":"Hepatitis C virus and kidney transplantation: recent trends and paradigm shifts","volume":"36","author":"Helou","year":"2022","journal-title":"Transplant Rev"},{"key":"10.1016\/j.trre.2026.101038_bb0035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.kint.2022.07.012","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"102","author":"Martin","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2026.101038_bb0040","author":"British transplantation society"},{"key":"10.1016\/j.trre.2026.101038_bb0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2026.101038_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.trre.2026.101038_bb0055","author":"West"},{"key":"10.1016\/j.trre.2026.101038_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2026.101038_bb0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1186\/s12885-025-14904-4","article-title":"Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis","volume":"25","author":"Bandala-Jacques","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trre.2026.101038_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/2047-1440-3-10","article-title":"Systematic review of melanoma incidence and prognosis in solid organ transplant recipients","volume":"3","author":"Dahlke","year":"2014","journal-title":"Transplant Res"},{"key":"10.1016\/j.trre.2026.101038_bb0075","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.34067\/KID.0000000000000450","article-title":"Short-term, mid-term, and long-term outcomes after deceased donor kidney transplantation in patients with AKI","volume":"5","author":"Scurt","year":"2024","journal-title":"Kidney360"},{"key":"10.1016\/j.trre.2026.101038_bb0080","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2026.101038_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2026.06.016","article-title":"Increasing access to kidney transplantation in an underserved population through a public-private partnership utilizing hepatitis C virus-infected donors","author":"Refaey","year":"2026","journal-title":"Transplant Proc."},{"key":"10.1016\/j.trre.2026.101038_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001827","article-title":"Outcomes of high kidney donor profile index hepatitis C nucleic acid testing positive kidneys are equivalent to matched hepatitis C nucleic acid testing negative kidneys","volume":"11","author":"He","year":"2025","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2026.101038_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/tid.70011","article-title":"Risk of cytomegalovirus viremia following transplantation of hepatitis C-viremic donor kidneys into uninfected recipients: a multi-center retrospective cohort study","volume":"27","author":"Potluri","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.transproceed.2023.11.006","article-title":"Kidney transplantation from brain-dead donors with hepatitis B or C in South Korea: a 2015 to 2020 Korean organ transplantation registry data analysis","volume":"56","author":"Park","year":"2024","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.sipas.2024.100236","article-title":"Donor hepatitis C status is not associated with an increased risk of acute rejection in kidney transplantation","volume":"16","author":"Johnson","year":"2024","journal-title":"Surgery Practice Sci"},{"key":"10.1016\/j.trre.2026.101038_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14364","article-title":"Incidence of opportunistic viral infections in hepatitis C virus nucleic acid test negative recipients of kidneys from hepatitis C virus nucleic acid test positive donors","volume":"26","author":"Shah","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajt.2022.11.005","article-title":"The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications","volume":"23","author":"Sutcliffe","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0120","article-title":"Twelve-month kidney and liver outcomes of kidney transplantation from hepatitis C viremic deceased donors to aviremic recipients","volume":"26","author":"Binari","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.transproceed.2022.12.015","article-title":"Kidney transplantation in an elderly veteran population with hepatitis C virus nucleic acid test\u2013positive donors results in improved outcomes after prophylactic Glecaprevir\/Pibrentasvir therapy","volume":"55","author":"Lopez-Soler","year":"2023","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5500\/wjt.v13.i2.44","article-title":"Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States","volume":"13","author":"Yuan","year":"2023","journal-title":"World J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0135","article-title":"Kidney transplant from HCV viremic donors to HCV-negative recipients and risk for de novo donor specific antibodies and acute rejection","volume":"37","author":"Daloul","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001217","article-title":"Kidney transplantation from hepatitis C viremic deceased donors to aviremic recipients in a real-world setting","volume":"7","author":"Concepcion","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2026.101038_bb0145","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1111\/ajt.16747","article-title":"Outcomes of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants","volume":"21","author":"Gupta","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0150","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2020.10.017","article-title":"Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes","volume":"77","author":"Molnar","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0155","article-title":"Hepatitis C-positive donor to negative recipient kidney transplantation: a real-world experience","volume":"23","author":"Jandovitz","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2026.101038_bb0160","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/tri.13743","article-title":"Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non-hepatitis C-infected donors: time to revise the kidney donor profile index \u2013 a retrospective cohort study","volume":"33","author":"Yazawa","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101038_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13833","article-title":"Transplantation of viral-positive hepatitis C-positive kidneys into uninfected recipients offers an opportunity to increase organ access","volume":"34","author":"Graham","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0170","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000002949","article-title":"Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C-positive recipients in the direct-acting antiviral era: time to revise the kidney donor risk index?","volume":"104","author":"Cannon","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101038_bb0175","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National Trends in utilization and 1-year outcomes with transplantation of HCV-Viremic kidneys","volume":"30","author":"Potluri","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2026.101038_bb0180","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/ajt.15496","article-title":"Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals","volume":"19","author":"La Hoz","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0185","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/ajt.14701","article-title":"Are we underestimating the quality of aviremic hepatitis C\u2013positive kidneys? Time to reconsider","volume":"18","author":"Sibulesky","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ckj\/sfx048","article-title":"Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes","volume":"10","author":"Cohen","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.trre.2026.101038_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13055","article-title":"Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: analysis of United States national data","volume":"31","author":"Gupta","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0200","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/TP.0000000000000479","article-title":"Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts","volume":"99","author":"Scalea","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101038_bb0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jss.2011.10.028","article-title":"Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease","volume":"176","author":"Flohr","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.trre.2026.101038_bb0210","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1399-0012.2011.01583.x","article-title":"The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience","volume":"26","author":"Singh","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0215","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients","volume":"10","author":"Morales","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101038_bb0220","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.transproceed.2010.04.056","article-title":"Kidney grafts from HCV-positive donors: advantages and disadvantages","volume":"42","author":"Maluf","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0225","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.transproceed.2005.06.066","article-title":"Kidney transplantation from hepatitis C virus\u2013positive donors into hepatitis C virus\u2013positive recipients: a safe way to expand the donor pool?","volume":"37","author":"Veroux","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0230","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0041-1345(02)03432-2","article-title":"Kidney transplantation from hepatitis C virus positive donors","volume":"34","author":"Rozental","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0235","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0041-1345(00)02681-6","article-title":"Transplantation of kidneys from anti-HCV positive donors","volume":"33","author":"Danielewicz","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101038_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.802686","article-title":"Efficacy and safety of direct-acting antivirals in kidney transplantation from HCV-viremic donors to negative recipients: a meta-analysis","volume":"9","author":"Feng","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.trre.2026.101038_bb0245","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jmv.23919","article-title":"Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies","volume":"86","author":"Fabrizi","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.trre.2026.101038_bb0250","author":"Risk of bias tools - robvis (visualization tool)"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:45:53Z","timestamp":1794487553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0955470X26000480"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101038","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of the impact of donor hepatitis C infection on kidney transplantation outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101038"}}